Affinage

GNG12

Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-12 · UniProt Q9UBI6

Length
72 aa
Mass
8.0 kDa
Annotated
2026-06-10
14 papers in source corpus 6 papers cited in narrative 6 extracted findings
Cross-family judge vs UniProt: Affinage preferred faithfulness: 5/5 claims corpus-supported (100%)

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

GNG12 (G protein subunit gamma 12) is a signaling adaptor that couples nutrient and inflammatory inputs to growth- and survival-promoting transcriptional and kinase pathways (PMID:30282607, PMID:31898405). At the lysosomal membrane, GNG12 is recruited in a leucine-dependent manner and interacts with the Ragulator complex to activate mTORC1, driving cell growth and casein synthesis (PMID:30282607). In cancer settings, GNG12 promotes proliferation and migration through two distinct pathway outputs: activation of NF-κB with consequent upregulation of PD-L1 in pancreatic ductal adenocarcinoma (PMID:31898405), and activation of PI3K/AKT signaling in glioma, where its knockdown reduces PI3K and AKT phosphorylation and tumor growth (PMID:35083664). GNG12 expression is constrained post-transcriptionally by microRNAs, being a direct target of miR-876-5p and of miR-599, the latter operating within an hsa_circ_0000285/miR-599/GNG12 regulatory axis in glioma (PMID:35083664, PMID:35060646). In microglia, GNG12 acts as a negative regulator of LPS-induced inflammation, with its depletion increasing nitrite and TNFα output (PMID:19568691).

Mechanistic history

Synthesis pass · year-by-year structured walk · 4 steps
  1. 2009 Medium

    Established the first functional role for GNG12 by showing it restrains inflammatory signaling rather than merely participating in it.

    Evidence RNAi knockdown in microglial BV-2 cells with nitrite and TNFα readouts following LPS stimulation

    PMID:19568691

    Open questions at the time
    • The molecular step at which GNG12 intercepts LPS signaling is not defined
    • No interacting partner identified in this inflammatory context
    • Single lab, single cell model
  2. 2018 Medium

    Placed GNG12 at the lysosomal membrane as a nutrient-responsive activator of mTORC1, defining a concrete molecular mechanism and binding partner.

    Evidence SWATH proteomics of lysosomal membrane, leucine-dependent localization, reciprocal Co-IP with Ragulator, and mTORC1 activation/functional rescue in cow mammary epithelial cells

    PMID:30282607

    Open questions at the time
    • Which Ragulator subunit GNG12 contacts is not resolved
    • How leucine triggers GNG12 lysosomal recruitment is unknown
    • Demonstrated in a single non-human epithelial system
  3. 2020 Medium

    Linked GNG12 to NF-κB-driven oncogenic output and immune evasion, broadening its role beyond mTORC1 to transcriptional control of PD-L1.

    Evidence Knockdown/overexpression with NF-κB pathway analysis, growth assays, and xenografts in pancreatic ductal adenocarcinoma

    PMID:31898405

    Open questions at the time
    • The mechanism by which GNG12 activates NF-κB is not defined
    • Direct binding partners upstream of NF-κB not identified
    • Single lab
  4. 2022 Medium

    Connected GNG12 to PI3K/AKT signaling in glioma and identified its post-transcriptional repression by microRNAs, integrating an upstream regulatory layer with downstream kinase output.

    Evidence Knockdown with PI3K/AKT phosphorylation readouts, proliferation/migration assays, xenografts, GSEA, and luciferase-validated miR-876-5p, miR-599, and hsa_circ_0000285 targeting

    PMID:35060646 PMID:35083664 PMID:35928884

    Open questions at the time
    • How GNG12 engages the PI3K/AKT cascade mechanistically is not established
    • Whether NF-κB, PI3K/AKT, and mTORC1 outputs share an upstream GNG12 activity is unresolved
    • Cell adhesion pathway involvement inferred from GSEA rather than direct assay

Open questions

Synthesis pass · forward-looking unresolved questions
  • It remains unknown whether GNG12's lysosomal/Ragulator, NF-κB, and PI3K/AKT activities reflect a single unifying biochemical function or context-specific roles, and the direct molecular activity of GNG12 itself is uncharacterized.
  • No defined enzymatic or binding activity assigned to GNG12 protein
  • No structural model of GNG12 complexes
  • Mechanistic link between distinct pathway outputs unestablished

Mechanism profile

Synthesis pass · controlled-vocabulary classification · explore literature graph →
Molecular activity
GO:0060089 molecular transducer activity 3
Localization
GO:0005764 lysosome 1
Pathway
R-HSA-162582 Signal Transduction 3
Partners

Evidence

Reading pass · 6 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
2009 GNG12 acts as a negative regulator of LPS-induced inflammation in microglial BV-2 cells; RNAi-mediated knockdown of Gng12 increased nitrite and TNFα levels following LPS stimulation, demonstrating a suppressive role in the inflammatory signaling cascade. RNAi knockdown with measurement of nitrite and TNFα levels as functional readouts Inflammation research Medium 19568691
2018 GNG12 localizes to the lysosomal membrane in a leucine-dependent manner and activates mTORC1 signaling by interacting with the Ragulator complex, thereby promoting cell growth and casein synthesis in cow mammary epithelial cells. SWATH mass spectrometry of lysosomal membrane proteins, overexpression/inhibition assays, co-immunoprecipitation with Ragulator, mTORC1 pathway activation readouts Biochimica et biophysica acta. Proteins and proteomics Medium 30282607
2020 GNG12 activates NF-κB signaling in pancreatic ductal adenocarcinoma cells, leading to upregulation of PD-L1 expression and promotion of cancer cell growth in vitro and in vivo. Cell growth assays (MTS, colony formation), xenograft mouse model, NF-κB signaling pathway analysis, GNG12 knockdown/overexpression FEBS open bio Medium 31898405
2022 GNG12 promotes glioma cell proliferation and migration via activation of the PI3K/AKT signaling pathway; knockdown of GNG12 reduced phosphorylation of PI3K and AKT and impaired tumor growth in vivo. GNG12 is a direct target of miR-876-5p, which suppresses GNG12 expression and downstream PI3K/AKT activity. qRT-PCR, western blot for PI3K/AKT phosphorylation, CCK-8 proliferation assay, wound healing assay, xenograft animal model, dual-luciferase reporter assay validating miR-876-5p targeting of GNG12 Journal of molecular neuroscience Medium 35083664
2022 GNG12 promotes glioma cell proliferation and migration; downregulation of GNG12 inhibited these processes, with GSEA and western blot experiments indicating involvement of the cell adhesion molecule signaling pathway. In vitro proliferation and migration assays, GSEA, western blot, GNG12 knockdown Frontiers in oncology Low 35928884
2022 hsa_circ_0000285 sponges miR-599, which in turn directly binds to GNG12 mRNA and negatively regulates GNG12 expression, establishing GNG12 as a downstream effector in the hsa_circ_0000285/miR-599/GNG12 axis that promotes glioma progression. RNA-binding protein immunoprecipitation, luciferase reporter assay, bioinformatic analysis, RT-qPCR, cell proliferation/migration assays, xenograft mouse model Journal of clinical laboratory analysis Medium 35060646

Source papers

Stage 0 corpus · 14 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
2016 Transcriptional silencing of long noncoding RNA GNG12-AS1 uncouples its transcriptional and product-related functions. Nature communications 70 26832224
2013 Imprinted chromatin around DIRAS3 regulates alternative splicing of GNG12-AS1, a long noncoding RNA. American journal of human genetics 34 23871723
2009 Gng12 is a novel negative regulator of LPS-induced inflammation in the microglial cell line BV-2. Inflammation research : official journal of the European Histamine Research Society ... [et al.] 34 19568691
2020 Whole Genome DNA Methylation Analysis of Active Pulmonary Tuberculosis Disease Identifies Novel Epigenotypes: PARP9/miR-505/RASGRP4/GNG12 Gene Methylation and Clinical Phenotypes. International journal of molecular sciences 24 32365959
2018 Proteomic analyses reveal GNG12 regulates cell growth and casein synthesis by activating the Leu-mediated mTORC1 signaling pathway. Biochimica et biophysica acta. Proteins and proteomics 24 30282607
2020 GNG12 regulates PD-L1 expression by activating NF-κB signaling in pancreatic ductal adenocarcinoma. FEBS open bio 23 31898405
2022 Checkpoints and immunity in cancers: Role of GNG12. Pharmacological research 17 35513227
2020 Lnc GNG12-AS1 knockdown suppresses glioma progression through the AKT/GSK-3β/β-catenin pathway. Bioscience reports 17 32735016
2021 Low GNG12 Expression Predicts Adverse Outcomes: A Potential Therapeutic Target for Osteosarcoma. Frontiers in immunology 14 34691083
2022 GNG12 as A Novel Molecular Marker for the Diagnosis and Treatment of Glioma. Frontiers in oncology 10 35928884
2022 GNG12 Targeted by miR-876-5p Contributes to Glioma Progression Through the Activation of the PI3K/AKT Signaling Pathway. Journal of molecular neuroscience : MN 7 35083664
2024 Long non-coding RNAs PTENP1, GNG12-AS1, MAGI2-AS3 and MEG3 as tumor suppressors in breast cancer and their associations with clinicopathological parameters. Cancer biomarkers : section A of Disease markers 6 38277283
2022 Circular RNA hsa_circ_0000285 regulates the microRNA-599/G-protein subunit gamma 12 (miR-599/GNG12) axis to promote glioma progression. Journal of clinical laboratory analysis 4 35060646
2023 PPARG, GNG12, and CD19 are potential independent predictors of central nerve recurrence in childhood acute lymphoblastic leukemia. Hematology (Amsterdam, Netherlands) 0 36861936

Missed literature

Know a paper Affinage missed for GNG12? Flag it for the maintainers and the community.

No submissions yet.